文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血血管内治疗后院内癫痫发作的危险因素:一项真实世界研究

Risk Factors for In-Hospital Seizures of Aneurysmal Subarachnoid Hemorrhage After Endovascular Treatment: A Real-World Study.
PubMed 文献 · World Neurosurg · 2024-05-28

本研究纳入3个中心2019年1月至2021年9月的547例动脉瘤性蛛网膜下腔出血患者,分析血管内治疗后院内癫痫发作的危险因素。28例(5.1%)发生院内癫痫。多因素分析显示改良Fisher评分、体重指数、动脉瘤纵横比和天冬氨酸转氨酶与癫痫风险相关。

要点

  • 547例动脉瘤性蛛网膜下腔出血血管内治疗患者中28例(5.1%)发生院内癫痫。
  • 改良Fisher评分调整OR为3.138(95%CI 1.226-8.036),与癫痫风险升高相关。
  • 体重指数调整OR为0.852(95%CI 0.749-0.970),与癫痫风险降低相关。

核心结论

  • 体重指数、天冬氨酸转氨酶、动脉瘤纵横比、改良Fisher评分和Hunt-Hess评分与血管内治疗后动脉瘤性蛛网膜下腔出血相关癫痫的发生相关。

研究设计与样本

  • 研究纳入3个中心2019年1月至2021年9月的547例动脉瘤性蛛网膜下腔出血患者。
  • 采用两种模型:模型1不调整变量,模型2纳入所有潜在混杂因素进行多因素logistic回归分析。
  • 使用限制性立方样条评估生物标志物与癫痫发生的剂量-反应关系。

主要发现

  • 547例患者中28例(5.1%)在住院期间发生癫痫。
  • 模型2中,改良Fisher评分调整OR为3.138(95%CI 1.226-8.036),与癫痫风险升高相关。
  • 模型2中,体重指数调整OR为0.852(95%CI 0.749-0.970),与癫痫风险降低相关。
  • 模型2中,动脉瘤纵横比调整OR为0.264(95%CI 0.115-0.604),与癫痫风险降低相关。
  • 模型2中,天冬氨酸转氨酶调整OR为1.017(95%CI 1.001-1.035),与癫痫风险升高相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The occurrence of in-hospital seizures for aneurysmal subarachnoid hemorrhage (aSAH) ranges from 3.7% to 15.2%, and seizures remain an important factor affecting patient prognosis. Therefore, the timely identification of patients at a higher risk for aSAH-associated seizures after endovascular treatment is of paramount importance. This study aims to analyze the risk factors for in-hospital seizures after endovascular treatment for aSAH. METHODS: The study comprised 547 patients at 3 centers from January 2019 to September 2021. In the context of this study, 2 models were utilized: the first model involved no variable adjustment, while the second model included all potential confounders in the multivariate logistic regression analysis. Additionally, the dose-response relationship between biomarkers and seizure occurrence was assessed using restricted cubic spline. RESULTS: Among these patients, 28 (5.1%) developed seizures during hospitalization. In Model 2, the modified Fisher score (adjusted odds ratio [OR]: 3.138, 95% confidence interval [CI]: 1.226-8.036), body mass index (adjusted OR: 0.852, 95% CI: 0.749-0.970), aspect ratio (adjusted OR: 0.264, 95% CI: 0.115-0.604), and aspartate transaminase (adjusted OR: 1.017, 95% CI: 1.001-1.035) were showed as factors contributing to an increased risk of aSAH-associated seizures. CONCLUSIONS: Body mass index, aspartate transaminase, aspect ratio, modified Fisher scores, and Hunt-Hess scores were correlated with the formation of aSAH-associated seizures after endovascular treatment.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Peng H, Qin Y, Zhang B, et al. Risk Factors for In-Hospital Seizures of Aneurysmal Subarachnoid Hemorrhage After Endovascular Treatment: A Real-World Study. World Neurosurg. 2024. PMID: 38815925. doi:10.1016/j.wneu.2024.05.140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。